CNS Pharmaceuticals, Inc. Common Stock (CNSP) is a publicly traded Healthcare sector company. As of October 2, 2026, CNSP trades at $5.24 with a market cap of $7.75M and a P/E ratio of -0.15. CNSP moved +0.00% today. Year to date, CNSP is -1.13%; over the trailing twelve months it is -39.77%. Its 52-week range spans $1.90 to $114.00. Rallies surfaces CNSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CNS Pharmaceuticals holds annual shareholder meeting, elects directors: CNS Pharmaceuticals held its annual shareholder meeting on Sept. 30, 2026. Shareholders approved raising authorized issuance under the 2020 Equity Plan by 650,000 shares to 765,061 and selected MaloneBailey, LLP as auditor for the year ending Dec. 31, 2026.
| Metric | Value |
|---|---|
| Price | $5.24 |
| Market Cap | $7.75M |
| P/E Ratio | -0.15 |
| EPS | $-35.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $114.00 |
| 52-Week Low | $1.90 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-15.85M |
| Gross Margin | 0.00% |
CNSP analyst coverage data. Average price target: $0.00.